home All News open_in_new Full Article

Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.

CAMBRIDGE, Mass. & MONTREAL — Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that following the announcement on November 14, 2025 of the entering into of a definitive arrangement agreement with XenoTherapeutics, Inc. and Xeno Acquisition Corp. (jointly, “Xeno”), a non-profit biotechnology company, pursuant to which Xeno […]


today 2 w. ago attach_file Other

attach_file Other
attach_file Society
attach_file Other
attach_file Sport
attach_file Other
attach_file Other
attach_file Economics
attach_file Other
attach_file Society
attach_file Economics


ID: 1136289899
Add Watch Country

arrow_drop_down